This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chee, C. B. E.
Right arrow Articles by Wang, Y. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chee, C. B. E.
Right arrow Articles by Wang, Y. T.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2008, p. 1935-1940, Vol. 46, No. 6
0095-1137/08/$08.00+0     doi:10.1128/JCM.02403-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Comparison of Sensitivities of Two Commercial Gamma Interferon Release Assays for Pulmonary Tuberculosis{triangledown}

Cynthia B. E. Chee,1* Suay H. Gan,1 Kyi W. KhinMar,1 Timothy M. Barkham,2 Chwee K. Koh,1 Shen Liang,3 and Yee T. Wang1

Singapore Tuberculosis Control Unit, Tan Tock Seng Hospital, Singapore, Republic of Singapore,1 Department of Pathology and Laboratory Medicine, Tan Tock Seng Hospital, Singapore, Republic of Singapore,2 Statistics Unit, Dean's Office, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Republic of Singapore3

Received 16 December 2007/ Returned for modification 25 January 2008/ Accepted 31 March 2008

There are few head-to-head comparisons of the commercial gamma interferon release assays (GIRAs). We compared the performance of the T-SPOT.TB and QuantiFERON-TB Gold In-Tube (QFT-IT) assays in patients with culture-proven pulmonary tuberculosis. Blood was drawn for both assays within 14 days of starting antituberculosis treatment. The QFT-IT indeterminate rate was 3.5%; the T-SPOT.TB failure rate was 1.4%. There was poor agreement between the GIRAs ({kappa} = 0.257) among the 270 patients with valid results for both tests. The sensitivities of the T-SPOT.TB and QFT-IT assays were 94.1 and 83.0%, respectively, with a significant difference in the performance of the assays (P = 0.001 [McNemar test]). Factors independently associated with indeterminate QFT-IT results were an age of ≥60 years (odds ratio [OR] 11.18, 95% confidence interval [CI] = 1.841 to 67.823, P = 0.009), female sex (OR = 7.47, 95% CI = 1.517 to 36.733, P = 0.013) and non-Chinese (i.e., Indian or Malay) race (OR = 7.89, 95% CI = 1.585 to 39.267, P = 0.012). The QFT-IT assay was significantly less sensitive in patients ≥60 years old (OR = 0.41, 95% CI = 0.181 to 0.918, P = 0.030) and in Indian compared to Chinese patients (OR = 0.27, 95% CI = 0.073 to 0.990, P = 0.048). The T-SPOT.TB assay was significantly less sensitive in Malay (OR = 0.23, 95% CI = 0.063 to 0.815, P = 0.023) and Indian patients (OR = 0.09, 95% CI = 0.017 to 0.429, P = 0.003) compared to Chinese patients. The performance of both assays was not significantly altered in diabetics. The diminished sensitivity of the GIRAs in persons of Malay and Indian race merits further study.


* Corresponding author. Mailing address: TB Control Unit, Dept. of Respiratory Medicine, Tan Tock Seng Hospital, 11, Jalan Tan Tock Seng, Singapore 308433, Republic of Singapore. Phone: 65 62566011. Fax: 65 63577871. E-mail: cynthia_chee{at}ttsh.com.sg

{triangledown} Published ahead of print on 9 April 2008.


Journal of Clinical Microbiology, June 2008, p. 1935-1940, Vol. 46, No. 6
0095-1137/08/$08.00+0     doi:10.1128/JCM.02403-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Inoue, T., Nakamura, T., Katsuma, A., Masumoto, S., Minami, E., Katagiri, D., Hoshino, T., Shibata, M., Tada, M., Hinoshita, F. (2009). The value of QuantiFERON(R)TB-Gold in the diagnosis of tuberculosis among dialysis patients. Nephrol Dial Transplant 24: 2252-2257 [Abstract] [Full Text]  
  • (2009). Interferon-gamma release assays and TB diagnosis. DTB 47: 67-70 [Abstract] [Full Text]  
  • Chen, X., Yang, Q., Zhang, M., Graner, M., Zhu, X., Larmonier, N., Liao, M., Yu, W., Deng, Q., Zhou, B. (2009). Diagnosis of Active Tuberculosis in China Using an In-House Gamma Interferon Enzyme-Linked Immunospot Assay. CVI 16: 879-884 [Abstract] [Full Text]